Search
for
Sort by
Research 30 of 1000+
- Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Scarring Alopecia in Tumor Necrosis Factor-α Antagonists-Induced Scalp Psoriasis
- ACTH as first line treatment for acute calcium pyrophosphate crystal arthritis in 14 hospitalized patients
- Hair-cycle changes in two patients taking tocilizumab
- SnapshotDx Quiz: September 2016
- Adverse Effects and Drug Interactions of Biologic Agents
- Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies
- Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review
- 17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes
- New treatments for rheumatoid arthritis
- Biologic: A Double Edged Sword - A Case of Etanercept Induced Alopecia Areata in a Patient with Psoriasis Vulgaris
- Increased Incidence of Telogen Effluvium Following Platelet-Rich Plasma Therapy in Patients with Elevated TNF-α Expression: A Prospective Cohort Study
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Cutaneous drug reactions
- Psoriasis and Alopecia: Unveiling the Links
- SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
- Ottawa, Ontario, Canada, February 13–16, 2013
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- Novel therapies for alopecia areata: The era of rational drug development
- Effect of <i>Ficus carica</i> leaf extract on the gene expression of selected factors in HaCaT cells
- 698 Effect of lithocholic acid as a ligand of vitamin D receptor on hair growth in alopecia
- Alopecia Areata following Adalimumab
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- Tumour Necrosis Factor Alpha, Interferon Gamma and Substance P Are Novel Modulators of Extrapituitary Prolactin Expression in Human Skin
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- Epidermal Notch1 recruits RORγ+ group 3 innate lymphoid cells to orchestrate normal skin repair